These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31096735)

  • 21. Disparities in the Diagnosis and Treatment of Bile Duct Cancer in People with Disabilities: A National Cohort Study in South Korea.
    Park SM; Kim SY; Yeob KE; Shin DW; Han JH; Park JH; Park JH
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in the National Cancer Screening Program for colorectal cancer in the Republic of Korea, 2004-2009.
    Park MJ; Choi KS; Jun JK; Lee HY
    Asian Pac J Cancer Prev; 2011; 12(12):3489-93. PubMed ID: 22471503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea.
    Cha JM; Suh M; Kwak MS; Sung NY; Choi KS; Park B; Jun JK; Hwang SH; Lee DH; Kim BC; Lee YK; Han DS
    Am J Gastroenterol; 2018 Apr; 113(4):611-621. PubMed ID: 29610512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends of Colorectal Cancer Screening Rates in Korea: Korean National Cancer Screening Survey 2005-2020.
    Park B; Lee YY; Song SY; Shin HY; Suh M; Choi KS; Jun JK
    Gut Liver; 2022 Nov; 16(6):930-941. PubMed ID: 35466090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the National Cancer Screening Program for Colorectal Cancer in Korea over 14 Years (2004-2017).
    Park B; Her EY; Lee K; Nari F; Jun JK; Choi KS; Suh M
    Cancer Res Treat; 2023 Jul; 55(3):910-917. PubMed ID: 36915246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic.
    Levi Z; Abu-Frecha N; Comanesther D; Backenstein T; Cohen AD; Eizenstein S; Flugelman A; Weinstein O
    J Med Screen; 2024 Jun; 31(2):85-90. PubMed ID: 37964557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of colorectal cancer screening between people with and without disability: a nationwide matched cohort study.
    Liao CM; Huang WH; Kung PT; Chiu LT; Tsai WC
    BMC Public Health; 2021 Jun; 21(1):1034. PubMed ID: 34078353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Widening disparities in the national prevalence of diabetes mellitus for people with disabilities in South Korea.
    Hwang I; Kim SY; Kim YY; Park JH
    Public Health; 2024 Jan; 226():173-181. PubMed ID: 38071950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
    Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
    BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factors affecting national health insurance mass screening participation in the disabled].
    Park JH; Lee JS; Lee JY; Hong JY; Kim SY; Kim SO; Cho BH; Kim YI; Shin Y; Kim Y
    J Prev Med Public Health; 2006 Nov; 39(6):511-9. PubMed ID: 17168205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
    Nielsen JB; Berg-Beckhoff G; Leppin A
    BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021.
    Luu XQ; Lee K; Jun JK; Suh M; Choi KS
    Epidemiol Health; 2023; 45():e2023086. PubMed ID: 37752795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal Cancer Screening Adherence in Selected Disabilities Over 10 Years.
    Deroche CB; McDermott SW; Mann JR; Hardin JW
    Am J Prev Med; 2017 Jun; 52(6):735-741. PubMed ID: 28214250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in the Colorectal Cancer Screening Rate by a Round-Mailed Fecal Immunochemical Testing Kit and Associated Factors in Underserved Regions of Korea: A Community-Based Intervention Study.
    Hong S; Shin HY; Lee B; Hwang NR; Hwang SH; Jun JK
    Gut Liver; 2020 May; 14(3):323-330. PubMed ID: 31530737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
    Koïvogui A; Mab GL; Benamouzig R
    Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea.
    Bui NC; Cho HN; Lee YY; Suh M; Park B; Jun JK; Kim Y; Choi KS
    Cancer Res Treat; 2018 Apr; 50(2):416-427. PubMed ID: 28494531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.